Luz Ibarra-Lara

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

International journal of molecular sciences

Instituto Nacional de Cardiología Ignacio Chávez

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Departamento de Farmacobiología Sede Sur (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Nacional de Cardiología Ignacio Chávez Jun 16 1998

Mexico

Investigadora en Ciencias Médicas :: Farmacología

Education History

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Departamento de Farmacobiología Sede Sur Feb 17 2009 - Mar 26 2013

Mexico

PHD :: Neurofarmacología y Terapéutica Experimental

Publications

Maria Sanchez-Aguilar, Luz Ibarra-Lara, Agustina Cano-Martínez, Elizabeth Soria-Castro, Vicente Castrejón-Téllez, Natalia Pavón, Citlalli Osorio-Yáñez, Eulises Díaz-Díaz, María Esther Rubio-Ruiz
PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International journal of molecular sciences 24 (6) (2023)
Maria Sanchez-Aguilar, Luz Ibarra-Lara, Agustina Cano-Martínez, Elizabeth Soria-Castro, Vicente Castrejón-Téllez, Natalia Pavón, Citlalli Osorio-Yáñez, Eulises Díaz-Díaz, María Esther Rubio-Ruiz
PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International journal of molecular sciences 24 (6) (2023)
Maria Sanchez-Aguilar, Luz Ibarra-Lara, Agustina Cano-Martínez, Elizabeth Soria-Castro, Vicente Castrejón-Téllez, Natalia Pavón, Citlalli Osorio-Yáñez, Eulises Díaz-Díaz, María Esther Rubio-Ruiz
PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International journal of molecular sciences 24 (6) (2023)
Fabiola Cortes-Lopez, Alicia Sanchez-Mendoza, David Centurión, Luz G Cervantes-Perez, Vicente Castrejón-Téllez, Leonardo Del Valle-Mondragon, Elizabeth Soria-Castro, Victoria Ramirez-Gonzalez, Araceli Sánchez-López, Gustavo Pastelin-Hernandez, Wylly Ramses Garcia-Niño, Maria Sanchez-Aguilar, Luz Ibarra-Lara
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects. PPAR research 2021 (2021)
Maria Sanchez-Aguilar, Luz Ibarra-Lara, Leonardo Del Valle-Mondragon, Elizabeth Soria-Castro, Juan Carlos Torres-Narváez, Elizabeth Carreón-Torres, Alicia Sanchez-Mendoza, María Esther Rubio-Ruiz
Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model. PPAR research 2020 (2020)
Luz Ibarra-Lara, Maria Sanchez-Aguilar, Elizabeth Soria-Castro, Jesús Vargas-Barrón, Francisco J Roldán, Natalia Pavón, Juan C Torres-Narváez, Luz G Cervantes-Pérez, Gustavo Pastelín-Hernández, Alicia Sanchez-Mendoza
Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model. Molecules (Basel, Switzerland) 24 (2) (2019)
Maria Sanchez-Aguilar, Luz Ibarra-Lara, Leonardo Del Valle-Mondragon, María Esther Rubio-Ruiz, Alicia G Aguilar-Navarro, Absalom Zamorano-Carrillo, Margarita Del Carmen Ramírez-Ortega, Gustavo Pastelín-Hernández, Alicia Sanchez-Mendoza
Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation. PPAR research 2019 (2019)

Luz Ibarra-Lara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luz Ibarra-Lara